Extra renal synthesis of 1,25-dihydroxyvitamin D and its health implications

被引:46
作者
Bikle D.D. [1 ]
机构
[1] Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, CA
来源
Clinical Reviews in Bone and Mineral Metabolism | 2009年 / 7卷 / 2期
关键词
Cancer; CYP27b1; Differentiation; FGF23; Immune function; Insulin; Keratinocytes; Macrophages; Parathyroid hormone; Proliferation;
D O I
10.1007/s12018-009-9033-y
中图分类号
学科分类号
摘要
Although the kidney was initially thought to be the sole organ responsible for the production of 1,25(OH)2D3 via its enzyme CYP27b1, it is now appreciated that the expression of CYP27b1 in tissues other than the kidney is wide spread. However, the kidney is the major source for circulating 1,25(OH)2D3. Therefore the existence of the capacity for extra renal 1,25(OH)2D3 production begs the question why, and in particular whether the extra renal production of 1,25(OH) 2D3 has physiologic importance. In this chapter this question will be discussed. First a compilation of the extra renal sites for CYP27b1 expression is provided. This is followed by a discussion of the regulation of CYP27b1 expression and activity in extra renal tissues, pointing out that such regulation is tissue specific and different from that of CYP27b1 in the kidney. Finally the physiologic significance of extra renal 1,25(OH) 2D3 production is examined, with special focus on the role of CYP27b1 in regulation of cellular proliferation and differentiation, hormone secretion, and immune function. At this point the data do not clearly demonstrate an essential role for CYP27b1 expression in any tissue outside the kidney, but several examples pointing in this direction are provided. With the availability of the mouse enabling tissue-specific deletion of CYP27b1, the role of extra renal CYP27b1 expression can now be addressed definitively. © Humana Press Inc. 2009.
引用
收藏
页码:114 / 125
页数:11
相关论文
共 143 条
[1]  
Fraser D.R., Kodicek E., Unique biosynthesis by kidney of a biological active vitamin D metabolite, Nature, 228, 5273, pp. 764-766, (1970)
[2]  
Gray T.K., Lester G.E., Lorenc R.S., Evidence for extra-renal 1 alpha-hydroxylation of 25-hydroxyvitamin D<sub>3</sub> in pregnancy, Science, 204, 4399, pp. 1311-1313, (1979)
[3]  
Weisman Y., Harell A., Edelstein S., 1alpha,25-Dihydroxyvitamin D<sub>3</sub> and 24,25-dihydroxyvitamin D<sub>3</sub> in vitro synthesis by human decidua and placenta, Nature, 281, 5729, pp. 317-319, (1979)
[4]  
Brumbaugh P.F., Et al., Filter assay for 1alpha, 25-dihydroxyvitamin D3. Utilization of the hormone's target tissue chromatin receptor, Biochemistry, 13, 20, pp. 4091-4097, (1974)
[5]  
Reeve L., Tanaka Y., DeLuca H.F., Studies on the site of 1,25 dihydroxyvitamin D<sub>3</sub> synthesis in vivo, Journal of Biological Chemistry, 258, 6, pp. 3615-3617, (1983)
[6]  
Shultz T.D., Fox J., Heath III H., Kumar R., Do tissues other than the kidney produce 1,25-dihydroxyvitamin D <sub>3</sub> in vivo? A reexamination, Proceedings of the National Academy of Sciences of the United States of America, 80, 6 I, pp. 1746-1750, (1983)
[7]  
Lambert P.W., Stern P.H., Avioli R.C., Evidence for extrarenal production of 1alpha,25-dihydroxyvitamin D in man, Journal of Clinical Investigation, 69, 3, pp. 722-725, (1982)
[8]  
Dusso A., Et al., Extra-renal production of calcitriol in chronic renal failure, Kidney Int, 34, 3, pp. 368-375, (1988)
[9]  
Littledike E.T., Horst R.L., Metabolism of vitamin D3 in nephrectomized pigs given pharmacological amounts of vitamin D3, Endocrinology, 111, 6, pp. 2008-2013, (1982)
[10]  
Barbour G.L., Coburn J.W., Slatopolsky E., Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal generation of 1,25-dihydroxyvitamin d, New England Journal of Medicine, 305, 8, pp. 440-443, (1981)